cyproterone


Also found in: Medical, Wikipedia.

cy·prot·er·one

 (sī-prŏt′ə-rōn′)
n.
A synthetic steroid that inhibits the secretion of androgens.

cyproterone

(saɪˈprɒtəˌrəʊn)
n
an antiandrogen drug that suppresses testosterone in the body
References in periodicals archive ?
EMAs safety committee (PRAC) has started a review of medicines containing cyproterone, which are used for treating a range of conditions, including excessive hair growth, prostate cancer and acne, as well as in hormone replacement therapy.
But Kazakhstan has purchased stocks of Cyproterone, a steroidal anti-androgen developed for fighting cancer, with doctors administering the injections.
This is similar to the concept behind the use of luteinizing hormone releasing hormone (LHRH) and cyproterone acetate (CPA) for prostate cancer.
In the control, 12 women used non-hormonal contraceptive methods, Ave used oral contraceptive methods such as levonorgestrel, ethinylestradiol, and cyproterone acetate, and three used injected contraceptive methods such as norethisterone enanthate, estradiol valerate, algestone acetophenide, and estradiol enanthate.
At the start of the study, participants then began a feminizing hormone therapy regimen of estradiol valerate (2 milligrams/day), a form of the female hormone estrogen, plus the androgen blocker cyproterone acetate (25 milligrams/day).
Among anti-androgen drugs, cyproterone acetate and medroxyprogesterone acetate can be given orally or as intramuscular depot injections.
After taking ethinylestradiol and cyproterone acetate tablets for 6 months, her menstrual pattern got normal.
Many different treatment modalities are available for the management of hirsutism in PCOS including non-pharmacological and pharmacological therapies like eflornithine OCPs, metformin, cyproterone acetate, and spironolactone.
A double-blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa.
Hurley Treatment Therapies by category stage modalities I Topical Antibiotics agents Clindamycin Gentamicin Dapsone Tetracyclines Clindamycin + rifampicin Resorcinol Systemic Antibiotics agents Rifampicin + moxifloxacin + metronidazole Ertapenem Meropenem Ceftriaxone Anti-androgens Ethinylestradiol Cyproterone acetate Finasteride Spironolactone Biguanides Metformin Surgical/ Surgical Laser Deroofing procedure Laser Nd:YAG C[O.sub.2] laser II-III (*) Systemic Biologics agents Etanercept Infliximab Adalimumab Ustekinumab Retinoids Acitretin Alitretinoin Immunosuppressants Methotrexate Cyclosporine Colchicine Surgical Wide radical excision (*) Includes Stage l treatment modalities
Data regarding the impact of COCs containing 35 [micro]g ethinylestradiol (EE) and 2 mg cyproterone acetate (CPA) on CRP levels of PCOS patients after 3-6 months of use were extracted from eleven articles, which were published in peer-reviewed journals between 2003 and 2016 [5, 16-25].
Hormone regime for transgender individuals receiving hormone therapy in New Zealand (2,11,27) Gender transition Hormone class Drug Options Female sex hormone Oestradiol valerate Male to female Estradot Anti-androgen Cyproterone acetate Spironolactone Testosterone Sustanon Female to male Male sex hormone Testosterone Cypionate (androgen) Testosterone Gender transition Dose (pre-gonadectomy) 2-8 mg/day (oral) Male to female 100 [micro]g 2x weekly (patch) 50-100 mg/day (oral) 100-200 mg/day (oral) 250mg/ml.
Full browser ?